Annual CFO
-$34.24 M
-$2.83 M-8.99%
December 31, 2023
Summary
- As of February 6, 2025, CADL annual cash flow from operations is -$34.24 million, with the most recent change of -$2.83 million (-8.99%) on December 31, 2023.
- During the last 3 years, CADL annual CFO has fallen by -$25.17 million (-277.51%).
- CADL annual CFO is now -561.46% below its all-time high of -$5.18 million, reached on December 31, 2019.
Performance
CADL Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFO
-$6.57 M
-$375.00 K-6.05%
September 30, 2024
Summary
- As of February 6, 2025, CADL quarterly cash flow from operations is -$6.57 million, with the most recent change of -$375.00 thousand (-6.05%) on September 30, 2024.
- Over the past year, CADL quarterly CFO has dropped by -$375.00 thousand (-6.05%).
- CADL quarterly CFO is now -336.74% below its all-time high of -$1.50 million, reached on September 30, 2020.
Performance
CADL Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFO
-$28.63 M
+$2.23 M+7.24%
September 30, 2024
Summary
- As of February 6, 2025, CADL TTM cash flow from operations is -$28.63 million, with the most recent change of +$2.23 million (+7.24%) on September 30, 2024.
- Over the past year, CADL TTM CFO has increased by +$2.23 million (+7.24%).
- CADL TTM CFO is now -1193.18% below its all-time high of -$2.21 million, reached on March 31, 2020.
Performance
CADL TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
CADL Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -9.0% | -6.0% | +7.2% |
| 3 y3 years | -277.5% | +4.5% | +8.9% |
| 5 y5 years | -561.5% | +4.5% | +8.9% |
CADL Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -54.1% | at low | -25.5% | +39.3% | -28.9% | +16.5% |
| 5 y | 5-year | -561.5% | at low | -336.7% | +39.3% | -1193.2% | +16.5% |
| alltime | all time | -561.5% | at low | -336.7% | +39.3% | -1193.2% | +16.5% |
Candel Therapeutics Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$6.57 M(+6.1%) | -$28.63 M(-7.2%) |
| Jun 2024 | - | -$6.20 M(-26.5%) | -$30.87 M(-3.1%) |
| Mar 2024 | - | -$8.44 M(+13.7%) | -$31.86 M(-7.0%) |
| Dec 2023 | -$34.24 M(+9.0%) | -$7.42 M(-15.7%) | -$34.24 M(+1.6%) |
| Sep 2023 | - | -$8.81 M(+22.4%) | -$33.71 M(-1.7%) |
| Jun 2023 | - | -$7.20 M(-33.5%) | -$34.28 M(+0.3%) |
| Mar 2023 | - | -$10.82 M(+57.1%) | -$34.19 M(+8.8%) |
| Dec 2022 | -$31.42 M | -$6.88 M(-26.6%) | -$31.42 M(+5.5%) |
| Sep 2022 | - | -$9.38 M(+32.2%) | -$29.77 M(+9.1%) |
| Jun 2022 | - | -$7.10 M(-11.9%) | -$27.28 M(+10.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$8.05 M(+53.7%) | -$24.64 M(+10.9%) |
| Dec 2021 | -$22.22 M(+144.9%) | -$5.24 M(-24.0%) | -$22.22 M(+8.9%) |
| Sep 2021 | - | -$6.89 M(+54.6%) | -$20.40 M(+35.9%) |
| Jun 2021 | - | -$4.46 M(-20.8%) | -$15.01 M(+20.2%) |
| Mar 2021 | - | -$5.63 M(+64.7%) | -$12.48 M(+37.6%) |
| Dec 2020 | -$9.07 M(+75.2%) | -$3.42 M(+127.0%) | -$9.07 M(+60.4%) |
| Sep 2020 | - | -$1.50 M(-22.3%) | -$5.66 M(+36.3%) |
| Jun 2020 | - | -$1.94 M(-12.6%) | -$4.15 M(+87.4%) |
| Mar 2020 | - | -$2.21 M | -$2.21 M |
| Dec 2019 | -$5.18 M | - | - |
FAQ
- What is Candel Therapeutics annual cash flow from operations?
- What is the all time high annual CFO for Candel Therapeutics?
- What is Candel Therapeutics annual CFO year-on-year change?
- What is Candel Therapeutics quarterly cash flow from operations?
- What is the all time high quarterly CFO for Candel Therapeutics?
- What is Candel Therapeutics quarterly CFO year-on-year change?
- What is Candel Therapeutics TTM cash flow from operations?
- What is the all time high TTM CFO for Candel Therapeutics?
- What is Candel Therapeutics TTM CFO year-on-year change?
What is Candel Therapeutics annual cash flow from operations?
The current annual CFO of CADL is -$34.24 M
What is the all time high annual CFO for Candel Therapeutics?
Candel Therapeutics all-time high annual cash flow from operations is -$5.18 M
What is Candel Therapeutics annual CFO year-on-year change?
Over the past year, CADL annual cash flow from operations has changed by -$2.83 M (-8.99%)
What is Candel Therapeutics quarterly cash flow from operations?
The current quarterly CFO of CADL is -$6.57 M
What is the all time high quarterly CFO for Candel Therapeutics?
Candel Therapeutics all-time high quarterly cash flow from operations is -$1.50 M
What is Candel Therapeutics quarterly CFO year-on-year change?
Over the past year, CADL quarterly cash flow from operations has changed by -$375.00 K (-6.05%)
What is Candel Therapeutics TTM cash flow from operations?
The current TTM CFO of CADL is -$28.63 M
What is the all time high TTM CFO for Candel Therapeutics?
Candel Therapeutics all-time high TTM cash flow from operations is -$2.21 M
What is Candel Therapeutics TTM CFO year-on-year change?
Over the past year, CADL TTM cash flow from operations has changed by +$2.23 M (+7.24%)